Portfolio Analysis Director

Myriad GeneticsSalt Lake City, UT
2dRemote

About The Position

The Portfolio Analysis Director will support enterprise-level decision making at a leading molecular diagnostics company by evaluating proposals for product portfolio, and long-term value creation initiatives. This role sits at the intersection of Corporate Strategy and Planning and Finance partnering closely with R&D, commercial, operations, and executive leadership to inform high-impact strategic decisions. The ideal candidate is a high-performing strategic thinker with a deal-side mindset, who combines strong analytical and financial modeling skills with a deep understanding of diagnostics markets, product development lifecycles and project portfolio composition.

Requirements

  • Bachelor’s degree in Business, Finance, Economics, or STEM related field
  • 4–7 years of experience in investment banking (healthcare group), or private equity
  • Expert-level proficiency in complex financial modeling and "clean-sheet" problem-solving
  • Experience working with ambiguous, incomplete data to support decision making
  • Excellent written and verbal communication skills

Nice To Haves

  • Experience in molecular diagnostics, life sciences, biotech, or healthcare
  • Familiarity with diagnostics product development lifecycles, regulatory pathways, and reimbursement considerations
  • Experience in corporate strategy and planning and/or strategic portfolio planning
  • MBA or CFA designation is highly preferred
  • Experience supporting executive or board-level strategy discussions

Responsibilities

  • Develop framework for opportunity and portfolio evaluation as part of annual 5-yr roadmap planning
  • Synthesize data across Market Intelligence and Product Strategy, Operations, Project Management, Tech, R&D, Finance and Data analytics teams
  • Evaluate strategic options across the molecular diagnostics portfolio, including product development, evidence generation, and infrastructure investments
  • Support portfolio prioritization decisions by assessing tradeoffs across risk, return, timing, and strategic fit
  • Update program and portfolio value for review at quarterly intervals and recommend project prioritization
  • Build and own enterprise financial models (DCF, NPV, IRR, scenario analysis) to assess long-term value creation of initiatives
  • Quantify the financial impact of potential R&D, operations, and product decisions
  • Partner with Finance and FP&A to align long-range plans with strategic priorities
  • Partner with Investor Relations to understand investor valuation perspectives of portfolio and financial decisions
  • Develop concise, executive-ready presentations and materials for senior leadership and board discussions
  • Translate financial information into clear recommendations
  • Support annual strategic planning and long-range planning processes
© 2024 Teal Labs, Inc
Privacy PolicyTerms of Service